![The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/46f7fe4a-1a50-4429-a1f0-8ae79f488772/jlb10304-gra-0001-m.jpg?trick=1695646083456)
The multiple faces of CD5 - Burgueño‐Bucio - 2019 - Journal of Leukocyte Biology - Wiley Online Library
![Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram](https://www.researchgate.net/publication/51175016/figure/fig4/AS:667848812793856@1536238973030/Expression-of-T-cell-surface-markers-on-CD5-KO-and-WT-mouse-TIL-A-TIL-from-a-pool-of.png)
Expression of T cell surface markers on CD5 KO and WT mouse TIL. A, TIL... | Download Scientific Diagram
Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written b
![Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram](https://www.researchgate.net/publication/11360352/figure/fig2/AS:281749927022611@1444185825802/Expression-of-surface-membrane-markers-on-B-CLL-cells-and-normal-CD5-B-cells-Surface.png)
Expression of surface membrane markers on B-CLL cells and normal CD5 ؉... | Download Scientific Diagram
![CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses | Science CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses | Science](https://www.science.org/cms/asset/fc94f077-3a2e-4462-90f1-3bd172441792/keyimage.gif)
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses | Science
![Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung](https://www.frontiersin.org/files/Articles/752104/fimmu-12-752104-HTML-r1/image_m/fimmu-12-752104-g001.jpg)
Frontiers | CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung
![The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy](https://www.cell.com/cms/attachment/a7cc7bdc-13e1-4ea0-9ce1-243f8dee8b24/fx1_lrg.jpg)
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy
![JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy](https://pub.mdpi-res.com/jcm/jcm-08-01802/article_deploy/html/images/jcm-08-01802-g001.png?1575027904)
JCM | Free Full-Text | Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy
![The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy](https://www.cell.com/cms/attachment/9aa77885-510d-47c4-92b7-e89b53b06622/gr4.jpg)
The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains: Molecular Therapy
![IJMS | Free Full-Text | Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia IJMS | Free Full-Text | Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia](https://www.mdpi.com/ijms/ijms-21-07685/article_deploy/html/images/ijms-21-07685-g001.png)
IJMS | Free Full-Text | Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia
![CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-023-01494-5/MediaObjects/41392_2023_1494_Fig1_HTML.png)
CD5: from antiquated T cell marker to immunotherapy's new hope | Signal Transduction and Targeted Therapy
![Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti- CD5 CAR T Cells | Stem Cell Reviews and Reports Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti- CD5 CAR T Cells | Stem Cell Reviews and Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12015-020-10092-9/MediaObjects/12015_2020_10092_Figa_HTML.png)
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti- CD5 CAR T Cells | Stem Cell Reviews and Reports
![T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00898-z/MediaObjects/41392_2022_898_Fig1_HTML.png)